Vanguard Group Inc Biomea Fusion, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,401,113 shares of BMEA stock, worth $4.85 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,401,113
Previous 1,397,897
0.23%
Holding current value
$4.85 Million
Previous $14.1 Million
61.5%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding BMEA
# of Institutions
126Shares Held
17.5MCall Options Held
1.8MPut Options Held
1.08M-
Cormorant Asset Management, LP Boston, MA3.57MShares$12.4 Million1.09% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$8.11 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.45MShares$5.02 Million0.06% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$2.76 Million1.14% of portfolio
-
State Street Corp Boston, MA604KShares$2.09 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $101M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...